Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury

David K. Wright, Jack Trezise, Alaa Kamnaksh, Ramsey Bekdash, Leigh A. Johnston, Roger Ordidge, Bridgette D. Semple, Andrew J. Gardner, Peter Stanwell, Terence J. O'Brien, Denes V. Agoston, Sandy R. Shultz

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)

Abstract

Repeated mild traumatic brain injuries (mTBI) may lead to serious neurological consequences, especially if re-injury occurs within the period of increased cerebral vulnerability (ICV) triggered by the initial insult. MRI and blood proteomics might provide objective measures of pathophysiological changes in mTBI, and indicate when the brain is no longer in a state of ICV. This study assessed behavioral, MRI, and blood-based markers in a rat model of mTBI. Rats were given a sham or mild fluid percussion injury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-injury. There were cognitive impairments for three days post-mFPI, before normalizing by day 5 post-injury. In contrast, advanced MRI (i.e., tractography) and blood proteomics (i.e., vascular endothelial growth factor) detected a number of abnormalities, some of which were still present 30 days post-mFPI. These findings suggest that MRI and blood proteomics are sensitive measures of the molecular and subtle structural changes following mTBI. Of particular significance, this study identified novel tractography measures that are able to detect mTBI and may be more sensitive than traditional diffusion-tensor measures. Furthermore, the blood and MRI findings may have important implications in understanding ICV and are translatable to the clinical setting.

Original languageEnglish
Article number28713
Number of pages16
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 28 Jun 2016
Externally publishedYes

Keywords

  • Magnetic Resonance Imaging
  • Mild traumatic brain injury
  • Diffusion weighted imaging
  • Biomarkers

Cite this

Wright, David K. ; Trezise, Jack ; Kamnaksh, Alaa ; Bekdash, Ramsey ; Johnston, Leigh A. ; Ordidge, Roger ; Semple, Bridgette D. ; Gardner, Andrew J. ; Stanwell, Peter ; O'Brien, Terence J. ; Agoston, Denes V. ; Shultz, Sandy R. / Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury. In: Scientific Reports. 2016 ; Vol. 6.
@article{5cf8b4f0d5f1449cad5624cb1d951c65,
title = "Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury",
abstract = "Repeated mild traumatic brain injuries (mTBI) may lead to serious neurological consequences, especially if re-injury occurs within the period of increased cerebral vulnerability (ICV) triggered by the initial insult. MRI and blood proteomics might provide objective measures of pathophysiological changes in mTBI, and indicate when the brain is no longer in a state of ICV. This study assessed behavioral, MRI, and blood-based markers in a rat model of mTBI. Rats were given a sham or mild fluid percussion injury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-injury. There were cognitive impairments for three days post-mFPI, before normalizing by day 5 post-injury. In contrast, advanced MRI (i.e., tractography) and blood proteomics (i.e., vascular endothelial growth factor) detected a number of abnormalities, some of which were still present 30 days post-mFPI. These findings suggest that MRI and blood proteomics are sensitive measures of the molecular and subtle structural changes following mTBI. Of particular significance, this study identified novel tractography measures that are able to detect mTBI and may be more sensitive than traditional diffusion-tensor measures. Furthermore, the blood and MRI findings may have important implications in understanding ICV and are translatable to the clinical setting.",
keywords = "Magnetic Resonance Imaging, Mild traumatic brain injury, Diffusion weighted imaging, Biomarkers",
author = "Wright, {David K.} and Jack Trezise and Alaa Kamnaksh and Ramsey Bekdash and Johnston, {Leigh A.} and Roger Ordidge and Semple, {Bridgette D.} and Gardner, {Andrew J.} and Peter Stanwell and O'Brien, {Terence J.} and Agoston, {Denes V.} and Shultz, {Sandy R.}",
year = "2016",
month = "6",
day = "28",
doi = "10.1038/srep28713",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury. / Wright, David K.; Trezise, Jack; Kamnaksh, Alaa; Bekdash, Ramsey; Johnston, Leigh A.; Ordidge, Roger; Semple, Bridgette D.; Gardner, Andrew J.; Stanwell, Peter; O'Brien, Terence J.; Agoston, Denes V.; Shultz, Sandy R.

In: Scientific Reports, Vol. 6, 28713, 28.06.2016.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury

AU - Wright, David K.

AU - Trezise, Jack

AU - Kamnaksh, Alaa

AU - Bekdash, Ramsey

AU - Johnston, Leigh A.

AU - Ordidge, Roger

AU - Semple, Bridgette D.

AU - Gardner, Andrew J.

AU - Stanwell, Peter

AU - O'Brien, Terence J.

AU - Agoston, Denes V.

AU - Shultz, Sandy R.

PY - 2016/6/28

Y1 - 2016/6/28

N2 - Repeated mild traumatic brain injuries (mTBI) may lead to serious neurological consequences, especially if re-injury occurs within the period of increased cerebral vulnerability (ICV) triggered by the initial insult. MRI and blood proteomics might provide objective measures of pathophysiological changes in mTBI, and indicate when the brain is no longer in a state of ICV. This study assessed behavioral, MRI, and blood-based markers in a rat model of mTBI. Rats were given a sham or mild fluid percussion injury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-injury. There were cognitive impairments for three days post-mFPI, before normalizing by day 5 post-injury. In contrast, advanced MRI (i.e., tractography) and blood proteomics (i.e., vascular endothelial growth factor) detected a number of abnormalities, some of which were still present 30 days post-mFPI. These findings suggest that MRI and blood proteomics are sensitive measures of the molecular and subtle structural changes following mTBI. Of particular significance, this study identified novel tractography measures that are able to detect mTBI and may be more sensitive than traditional diffusion-tensor measures. Furthermore, the blood and MRI findings may have important implications in understanding ICV and are translatable to the clinical setting.

AB - Repeated mild traumatic brain injuries (mTBI) may lead to serious neurological consequences, especially if re-injury occurs within the period of increased cerebral vulnerability (ICV) triggered by the initial insult. MRI and blood proteomics might provide objective measures of pathophysiological changes in mTBI, and indicate when the brain is no longer in a state of ICV. This study assessed behavioral, MRI, and blood-based markers in a rat model of mTBI. Rats were given a sham or mild fluid percussion injury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-injury. There were cognitive impairments for three days post-mFPI, before normalizing by day 5 post-injury. In contrast, advanced MRI (i.e., tractography) and blood proteomics (i.e., vascular endothelial growth factor) detected a number of abnormalities, some of which were still present 30 days post-mFPI. These findings suggest that MRI and blood proteomics are sensitive measures of the molecular and subtle structural changes following mTBI. Of particular significance, this study identified novel tractography measures that are able to detect mTBI and may be more sensitive than traditional diffusion-tensor measures. Furthermore, the blood and MRI findings may have important implications in understanding ICV and are translatable to the clinical setting.

KW - Magnetic Resonance Imaging

KW - Mild traumatic brain injury

KW - Diffusion weighted imaging

KW - Biomarkers

UR - http://www.scopus.com/inward/record.url?scp=84976344642&partnerID=8YFLogxK

U2 - 10.1038/srep28713

DO - 10.1038/srep28713

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 28713

ER -